IL7R and neoplasm: These findings indicate that high IL7R expression promotes p-STAT1 activation, driving cisplatin resistance and migration in p53R175G cells, while IL7R pharmacological inhibition markedly suppresses tumor progression and enhances the efficacy of cisplatin treatment.